Correction to ‘The early injected genomic region determines sensitivity to Type I restriction-modification defence against Autographiviridae phages ’ | Synapse
March 3, 2026Open Access
Correction to ‘The early injected genomic region determines sensitivity to Type I restriction-modification defence against Autographiviridae phages ’
Key Points
Sensitivity to Type I restriction-modification defence is determined by the genomic region injected early during infection.
The correction highlights the specific genomic region's role, impacting how phages interact with their host.
Observational analysis highlights the implications of genomic characteristics on phage susceptibility and defence.
This finding supports further exploration of genomic influences on viral resistance and phage therapy interventions.